PEDEvidence

SOURCE-LINKED STUDY SUMMARY

Efficacy of icariin in polycystic ovary syndrome: Cathepsin S as a key target revealed by computational and experimental evidence.

Bioorganic chemistry ·

Study type unconfirmed

Abstract summarized · Quality not appraised
Studied
Combined computer analyses and an animal experiment investigating icariin in polycystic ovary syndrome.
Who / model
Mice with DHEA-induced polycystic ovary syndrome, with measurements in ovarian granulosa cells. Mouse numbers, comparator details and treatment duration are not stated.
Studied dose & schedule
Dose and schedule have not yet been extracted for this summary.
Found
Icariin-treated mice had lower testosterone, more regular reproductive cycles, fewer cystic follicles and more corpora lutea. Cathepsin S expression decreased in ovarian cells. Computer simulations identified this protein as a possible target; additional pathway changes came from virtual predictions.
Limits
Study limitations were not stated in the abstract. Methodological quality has not been appraised.

Read summary source ↗ · Prepared 9/16/2026 · AI-assisted, source-based summary

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.1016/j.bioorg.2026.110474

Explore related compounds

How summaries and evidence labels are prepared

← All study summaries